FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
Revenue of FDC Limited (FDC.NS)
Revenue in 2023 (TTM): $230.2 M
According to FDC Limited's latest financial reports the company's current revenue (TTM) is $230.2 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of FDC Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $230.2 M | $78.03 M | $40.11 M | $46.94 M | $36.16 M |
| 2022 | $211.33 M | $133.64 M | $35.64 M | $30.54 M | $22.99 M |
| 2021 | $180.77 M | $115.91 M | $39.07 M | $34.29 M | $25.64 M |
| 2020 | $157.2 M | $106.61 M | $50.82 M | $45.94 M | $35.7 M |
| 2019 | $158.45 M | $106.71 M | $42.87 M | $37.91 M | $28.42 M |
| 2018 | $128.54 M | $86.19 M | $32.39 M | $28.04 M | $20.12 M |
| 2017 | $126.83 M | $83.38 M | $32.9 M | $28.51 M | $20.56 M |
| 2016 | $119.54 M | $78.27 M | $28.84 M | $29.84 M | $22.34 M |
| 2015 | $118.62 M | $75.13 M | $31.72 M | $26.06 M | $18.56 M |
| 2014 | $105.06 M | $64.21 M | $28.94 M | $24.13 M | $17.55 M |
| 2013 | $99.82 M | $60.6 M | $29.2 M | $25.87 M | $16.03 M |
| 2012 | $91.23 M | $53.98 M | $26.88 M | $23.43 M | $18.38 M |
| 2011 | $84.18 M | $47.21 M | $22.74 M | $20.4 M | $15.89 M |
| 2010 | $83.84 M | $48.39 M | $22.97 M | $20.78 M | $17.88 M |
| 2009 | $78.37 M | $44.18 M | $23.45 M | $21.4 M | $17.67 M |
| 2008 | $69.8 M | $37.77 M | $14.54 M | $12.8 M | $10.21 M |
| 2007 | $58.66 M | $28.45 M | $10.43 M | $8.92 M | $7.48 M |
| 2006 | $51.12 M | $25.68 M | $11.47 M | $9.85 M | $7.77 M |
| 2005 | $41.48 M | $22.26 M | $11.07 M | $10.06 M | $8.28 M |
| 2004 | $38.95 M | $18.57 M | $9.41 M | $8.33 M | $6.51 M |